Spinnaker ETF Series - North Shore Equity Rotation ETF
US ˙ ARCA ˙ US1571313014

Introduction

This page provides a comprehensive analysis of the known insider trading history of Craig W Moore. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Craig W Moore has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:NXTM / NxStage Medical, Inc. Director 0
US:KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Director 4,500
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Craig W Moore. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Insider Trades
Insider Sales KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Craig W Moore as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2019-02-25 2019-02-21 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -15,643 0 -100.00
2019-02-25 2019-02-21 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -15,854 0 -100.00
2019-02-25 2019-02-21 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -19,724 0 -100.00
2019-02-25 2019-02-21 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -23,394 0 -100.00
2019-02-25 2019-02-21 4 NXTM NxStage Medical, Inc.
Common Stock
D - Sale to Issuer -105,439 0 -100.00 30.00 -3,163,170
2019-02-25 2019-02-21 4 NXTM NxStage Medical, Inc.
Common Stock
D - Sale to Issuer -3,745 0 -100.00 30.00 -112,350
2018-05-18 2018-05-16 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
M - Exercise -7,700 0 -100.00
2018-05-18 2018-05-16 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
M - Exercise -10,496 0 -100.00
2018-05-18 2018-05-16 4 NXTM NxStage Medical, Inc.
Common Stock
F - Taxes -3,955 3,745 -51.36 26.48 -104,728 99,168
2018-05-18 2018-05-16 4 NXTM NxStage Medical, Inc.
Common Stock
M - Exercise 7,700 7,700 13.60 104,720 104,720
2018-05-18 2018-05-16 4 NXTM NxStage Medical, Inc.
Common Stock
M - Exercise 10,496 105,439 11.06 13.60 142,746 1,433,970
2017-05-26 2017-05-25 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
A - Award 15,643 15,643
2017-03-16 2017-03-16 4 NXTM NxStage Medical, Inc.
Common Stock
S - Sale -1,000 94,943 -1.04 27.93 -27,930 2,651,758
2017-02-02 2017-02-01 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
M - Exercise -15,272 0 -100.00
2017-02-02 2017-02-01 4 NXTM NxStage Medical, Inc.
Common Stock
F - Taxes -8,568 95,943 -8.20 26.72 -228,937 2,563,597
2017-02-02 2017-02-01 4 NXTM NxStage Medical, Inc.
Common Stock
M - Exercise 15,272 104,511 17.11 14.99 228,927 1,566,620
2016-09-14 2016-09-14 4 NXTM NxStage Medical, Inc.
Common Stock
S - Sale -1,500 89,239 -1.65 23.60 -35,400 2,106,040
2016-09-14 2016-09-12 4 NXTM NxStage Medical, Inc.
Common Stock
S - Sale -1,500 90,739 -1.63 23.02 -34,530 2,088,812
2016-07-06 2016-07-01 4 KOOL CESCA THERAPEUTICS INC.
Stock Options
A - Award 1,250 4,500 38.46
2016-07-06 2016-07-01 4 KOOL CESCA THERAPEUTICS INC.
Common Stock
A - Award 1,737 7,788 28.71 2.86 4,968 22,274
2016-05-27 2016-05-26 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
A - Award 15,854 15,854
2016-05-27 2016-05-25 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
M - Exercise -14,000 0 -100.00
2016-05-27 2016-05-25 4 NXTM NxStage Medical, Inc.
Common Stock
F - Taxes -13,807 92,239 -13.02 18.81 -259,710 1,735,016
2016-05-27 2016-05-25 4 NXTM NxStage Medical, Inc.
Common Stock
M - Exercise 14,000 106,046 15.21 18.55 259,700 1,967,153
2016-04-05 2016-04-01 4 KOOL CESCA THERAPEUTICS INC.
Common Stock
A - Award 1,239 6,051 25.75 4.01 4,968 24,265
2015-11-20 2015-11-20 4 NXTM NxStage Medical, Inc.
Common Stock
S - Sale X -1,000 92,046 -1.07 20.00 -20,000 1,840,920
2015-11-18 2015-11-18 4 NXTM NxStage Medical, Inc.
Common Stock
S - Sale X -4,000 93,046 -4.12 19.60 -78,400 1,823,702
2015-10-09 2015-09-30 4 KOOL CESCA THERAPEUTICS INC.
Common Stock
A - Award 9,375 96,223 10.79 0.53 4,969 50,998
2015-09-16 2015-09-15 4 NXTM NxStage Medical, Inc.
Common Stock
S - Sale -1,000 97,046 -1.02 16.00 -16,000 1,552,736
2015-07-02 2015-07-01 4 KOOL CESCA THERAPEUTICS INC.
Option
A - Award 25,000 80,000 45.45
2015-07-02 2015-06-30 4 KOOL CESCA THERAPEUTICS INC.
Common Stock
A - Award 5,846 86,848 7.22 0.85 4,969 73,821
2015-05-26 2015-05-21 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
A - Award 19,724 19,724
2015-05-22 2015-05-20 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
M - Exercise -14,000 0 -100.00
2015-05-22 2015-05-20 4 NXTM NxStage Medical, Inc.
Common Stock
F - Taxes -11,478 98,046 -10.48 16.93 -194,323 1,659,919
2015-05-22 2015-05-20 4 NXTM NxStage Medical, Inc.
Common Stock
M - Exercise 14,000 109,524 14.66 13.88 194,320 1,520,193
2015-04-02 2015-03-31 4 KOOL CESCA THERAPEUTICS INC.
Common Stock
A - Award 5,799 81,002 7.71 0.90 5,219 72,902
2015-01-05 2014-12-31 4 KOOL CESCA THERAPEUTICS INC.
Common Stock
A - Award 5,116 75,203 7.30 1.02 5,218 76,707
2014-10-02 2014-09-30 4 KOOL CESCA THERAPEUTICS INC.
Common Stock
A - Award 8,555 70,087 13.90 1.22 10,437 85,506
2014-07-02 2014-07-01 4 KOOL CESCA THERAPEUTICS INC.
Option
A - Award 25,000 95,000 35.71
2014-07-02 2014-06-30 4 KOOL CESCA THERAPEUTICS INC.
Common Stock
A - Award 7,509 61,532 13.90 1.39 10,438 85,529
2014-05-27 2014-05-22 4 NXTM NxStage Medical, Inc.
Stock Option (Right to Buy)
A - Award 23,394 23,394
2014-04-03 2014-03-31 4 KOOL CESCA THERAPEUTICS INC.
Common Stock
A - Award 6,140 54,023 12.82 1.70 10,438 91,839
2014-03-07 2014-03-05 4 NXTM NxStage Medical, Inc.
Stock Option (right to buy)
M - Exercise -14,000 0 -100.00
2014-03-07 2014-03-05 4 NXTM NxStage Medical, Inc.
Common Stock
F - Taxes -3,226 95,524 -3.27 14.67 -47,325 1,401,337
2014-03-07 2014-03-05 4 NXTM NxStage Medical, Inc.
Common Stock
M - Exercise 14,000 98,750 16.52 3.38 47,320 333,775
2014-01-03 2013-12-31 4 KOOL THERMOGENESIS CORP
Common Stock
A - Award 5,393 47,883 12.69 1.02 5,500 48,836
2013-10-02 2013-09-30 4 KOOL THERMOGENESIS CORP
Common Stock
A - Award 5,093 42,490 13.62 1.08 5,500 45,889
2013-07-02 2013-07-01 4 KOOL THERMOGENESIS CORP
Option
A - Award 15,000 76,250 24.49
2013-07-02 2013-06-28 4 KOOL THERMOGENESIS CORP
Common Stock
A - Award 5,926 37,397 18.83 1.35 8,000 50,486
2013-05-28 2013-05-23 4 NXTM NxStage Medical, Inc.
Stock Option (right to buy)
A - Award 18,196 18,196
2013-04-04 2013-03-28 4 KOOL THERMOGENESIS CORP
Common Stock
A - Award 6,471 31,471 25.88 0.85 5,500 26,750
2013-03-14 2013-03-13 4 NXTM NxStage Medical, Inc.
Stock Option (right to buy)
M - Exercise -14,000 0 -100.00
2013-03-14 2013-03-13 4 NXTM NxStage Medical, Inc.
Common Stock
F - Taxes -6,637 84,750 -7.26 11.37 -75,463 963,608
2013-03-14 2013-03-13 4 NXTM NxStage Medical, Inc.
Common Stock
M - Exercise 14,000 91,387 18.09 5.39 75,460 492,576
2012-07-05 2012-07-02 4 KOOL THERMOGENESIS CORP
Option
A - Award 15,000 61,250 32.43
2012-05-25 2012-05-24 4 NXTM NxStage Medical, Inc.
Stock Option (right to buy)
A - Award 15,272 15,272
2012-05-25 2012-05-24 4 NXTM NxStage Medical, Inc.
Stock Option (right to buy)
M - Exercise -14,000 0 -100.00
2012-05-25 2012-05-24 4 NXTM NxStage Medical, Inc.
Common Stock
M - Exercise 14,000 77,387 22.09 12.20 170,800 944,121
2012-01-31 2012-01-27 4 KOOL THERMOGENESIS CORP
Common Stock
A - Award 25,000 25,000 1.02 25,500 25,500
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)